Author Aktas, Orhan
-
2004 | Journal Article
Identification and functional characterization of a highly polymorphic region in the human TRAIL promoter in multiple sclerosis
Weber, A.; Wandinger, K.-P.; Mueller, W.; Aktas, O.; Wengert, O.; Grundstrom, E. & Ehrlich, S. et al. (2004)
Journal of Neuroimmunology, 149(1-2) pp. 195-201. DOI: https://doi.org/10.1016/j.jneuroim.2003.12.014
Details DOI PMID PMC WoS
-
2009 | Journal Article |
Beyond blood brain barrier breakdown – in vivo detection of occult neuroinflammatory foci by magnetic nanoparticles in high field MRI
Tysiak, E.; Asbach, P.; Aktas, O.; Waiczies, H.; Smyth, M.; Schnorr, J. & Taupitz, M. et al. (2009)
Journal of Neuroinflammation, 6(1) pp. 20. DOI: https://doi.org/10.1186/1742-2094-6-20
Details DOI
-
2012 | Conference Abstract
Diagnostic biopsy of spinal tumours: need for prior aquaporin-4 antibody testing
Ringelstein, M.; Metz, I.; Ruprecht, K.; Koch, A.; Rappold, J.; Harmel, J. & Mathys, C. et al. (2012)
Multiple Sclerosis Journal, 18 pp. 69-70. 28th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis, Lyon, FRANCE.
London: Sage Publications Ltd.
Details WoS
-
2012 | Journal Article |
Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients
Jarius, S.; Ruprecht, K.; Wildemann, B.; Kuempfel, T.; Ringelstein, M.; Geis, C. & Kleiter, I. et al. (2012)
Journal of Neuroinflammation, 9 art. 14. DOI: https://doi.org/10.1186/1742-2094-9-14
Details DOI PMID PMC WoS
-
2014 | Journal Article |
Contribution of spinal cord biopsy to diagnosis of aquaporin-4 antibody positive neuromyelitis optica spectrum disorder
Ringelstein, M.; Metz, I.; Ruprecht, K.; Koch, A.; Rappold, J.; Ingwersen, J. & Mathys, C. et al. (2014)
Multiple Sclerosis Journal, 20(7) pp. 882-888. DOI: https://doi.org/10.1177/1352458513510981
Details DOI PMID PMC WoS
-
2015 | Review |
Neuromyelitis optica and multiple sclerosis: Seeing differences through optical coherence tomography
Bennett, J. L.; de Seze, J.; Lana-Peixoto, M. A.; Palace, J.; Waldman, A.; Schippling, S.& Tenembaum, S. N. et al. (2015)
Multiple Sclerosis Journal, 21(6) pp. 678-688.
Sage Publications Ltd. DOI: https://doi.org/10.1177/1352458514567216
Details DOI PMID PMC WoS
-
2016 | Journal Article |
Treatment of optic neuritis with erythropoietin (TONE): a randomised, double-blind, placebo-controlled trialstudy protocol
Diem, R.; Molnar, F.; Beisse, F.; Gross, N.; Drueschler, K.; Heinrich, S. P. & Joachimsen, L. et al. (2016)
BMJ Open, 6(3) art. e010956. DOI: https://doi.org/10.1136/bmjopen-2015-010956
Details DOI PMID PMC WoS
-
2016 | Journal Article |
Serum peptide reactivities may distinguish neuromyelitis optica subgroups and multiple sclerosis
Metz, I. ; Beißbarth, T. ; Ellenberger, D. ; Pache, F.; Stork, L.; Ringelstein, M. & Aktas, O. et al. (2016)
Neurology: Neuroimmunology & Neuroinflammation, 3(2) art. e204. DOI: https://doi.org/10.1212/NXI.0000000000000204
Details DOI PMID PMC
-
2017 | Journal Article
Immunotherapies in neuromyelitis optica spectrum disorder: efficacy and predictors of response
Stellmann, J.-P.; Krumbholz, M.; Friede, T. ; Gahlen, A.; Borisow, N.; Fischer, K. & Hellwig, K. et al. (2017)
Journal of Neurology, Neurosurgery & Psychiatry, 88(8) pp. 639-647. DOI: https://doi.org/10.1136/jnnp-2017-315603
Details DOI
-
2018 | Journal Article
Neuroimmunologische Register in Deutschland
Thiel, S.; Leypoldt, F.; Röpke, L.; Wandinger, K.; Kümpfel, T.; Aktas, O. & von Bismarck, O. et al. (2018)
Aktuelle Neurologie, 45(01) pp. 7-23. DOI: https://doi.org/10.1055/s-0043-108909
Details DOI
-
2020 | Journal Article
Case Report: A Case of Severe Clinical Deterioration in a Patient With Multiple Sclerosis
Breitkopf, K.; Aytulun, A.; Förster, M.; Kraus, B.; Turowski, B.; Huppert, D. & Goebels, N. et al. (2020)
Frontiers in Neurology, 11. DOI: https://doi.org/10.3389/fneur.2020.00782
Details DOI
-
2020 | Journal Article
Anti-CD20 therapies and pregnancy in neuroimmunologic disorders
Kümpfel, T.; Thiel, S.; Meinl, I.; Ciplea, A. I.; Bayas, A.; Hoffmann, F. & Hofstadt-van Oy, U. et al. (2020)
Neurology - Neuroimmunology Neuroinflammation, 8(1) pp. e913. DOI: https://doi.org/10.1212/NXI.0000000000000913
Details DOI
-
2020 | Journal Article
Longitudinal optic neuritis-unrelated visual evoked potential changes in NMO spectrum disorders
Ringelstein, M.; Harmel, J.; Zimmermann, H.; Brandt, A. U.; Paul, F.; Haarmann, A. & Buttmann, M. et al. (2020)
Neurology, 94(4) pp. e407-e418. DOI: https://doi.org/10.1212/WNL.0000000000008684
Details DOI
-
2020 | Journal Article |
Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: Results from 163 lumbar punctures in 100 adult patients
Jarius, S.; Pellkofer, H. ; Siebert, N.; Korporal-Kuhnke, M.; Hümmert, M. W.; Ringelstein, M. & Rommer, P. S. et al. (2020)
Journal of Neuroinflammation, 17(1). DOI: https://doi.org/10.1186/s12974-020-01824-2
Details DOI
-
2021 | null
The APOSTEL 2.0 Recommendations for Reporting Quantitative Optical Coherence Tomography Studies
Aytulun, A.; Cruz-Herranz, A.; Aktas, O.; Balcer, L. J.; Balk, L.; Barboni, P. & Blanco, A. A. et al. (2021)
Neurology, pp. 10.1212/WNL.0000000000012125. DOI: https://doi.org/10.1212/WNL.0000000000012125
Details DOI
-
2021 | Journal Article
Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper)
Wiendl, H.; Gold, R. ; Berger, T.; Derfuss, T.; Linker, R. ; Mäurer, M. & Aktas, O. et al. (2021)
Therapeutic Advances in Neurological Disorders, 14 pp. 175628642110396. DOI: https://doi.org/10.1177/17562864211039648
Details DOI
-
2023 | Journal Article
Time to disability milestones and annualized relapse rates in NMOSD and MOGAD
Duchow, A.; Bellmann‐Strobl, J.; Friede, T.; Aktas, O.; Angstwurm, K.; Ayzenberg, I. & Berthele, A. et al. (2023)
Annals of Neurology, art. ana.26858. DOI: https://doi.org/10.1002/ana.26858
Details DOI